Clinical Trial Update: Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency [Phase 4]

View source ↗

Summary

Update on a Phase 4 clinical trial evaluating pegylated somatropin for treatment of growth hormone deficiency in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Pegylated Somatropin (pegylated human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Growth Hormone Deficiency | Phase 4 | Status: UNKNOWN